Cadence Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-35,238
Closed -$3.07M – 690
2017
Q2
$3.07M Buy
35,238
+266
+0.8% +$22.5K 0.21% 118
2017
Q1
$3.11M Buy
34,972
+624
+2% +$52K 0.21% 113
2016
Q4
$2.54M Buy
34,348
+3,215
+10% +$241K 0.18% 137
2016
Q3
$2.35M Buy
31,133
+3,056
+11% +$234K 0.17% 149
2016
Q2
$2.16M Buy
28,077
+10,037
+56% +$792K 0.16% 159
2016
Q1
$1.41M Buy
+18,040
New +$1.26M 0.1% 233
2015
Q4
– Sell
-18,850
Closed -$1.46M – 625
2015
Q3
$1.46M Hold
18,850
– – 0.1% 222
2015
Q2
$1.71M Hold
18,850
– – 0.1% 265
2015
Q1
$1.42M Sell
18,850
-4,660
-20% -$335K 0.09% 296
2014
Q4
$1.73M Sell
23,510
-30
-0.1% -$2.11K 0.1% 259
2014
Q3
$1.66M Sell
23,540
-84,860
-78% -$5.61M 0.09% 273
2014
Q2
$6.11M Sell
108,400
-15,700
-13% -$828K 0.29% 106
2014
Q1
$6.51M Sell
124,100
-1,870
-1% -$93.1K 0.27% 116
2013
Q4
$6.01M Sell
125,970
-11,800
-9% -$545K 0.23% 157
2013
Q3
$5.89M Buy
+137,770
New +$5.38M 0.2% 220

Other funds holding HCA

Cadence Capital Management's HCA Position: Q3 2017 in Review

Cadence Capital Management sold out of HCA Healthcare (HCA) in Q3 2017, closing a stake of 35,238 shares — an estimated $3.07M sold.

Cadence Capital Management first reported a position in HCA in Q3 2013 and held it in 15 quarters. The position peaked at $6.51M in Q1 2014. 529 funds tracked by Wall St. Rank hold HCA as of Q3 2017.

  • Cadence Capital Management reported no remaining HCA Healthcare position as of Q3 2017 after selling out during the quarter.
  • Cadence Capital Management sold 35,238 HCA Healthcare shares in Q3 2017, an estimated $3.07M.
  • Cadence Capital Management first reported a position in HCA Healthcare in Q3 2013 and held it in 15 quarters.
  • Cadence Capital Management's HCA Healthcare position peaked at $6.51M in Q1 2014.
  • 529 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2017.

Based on Cadence Capital Management's 13F filing for Q3 2017, filed 9 Nov 2017.